5 best EDC platforms for respiratory clinical trials in 2026

A COPD (chronic obstructive pulmonary disease) or asthma trial rarely stays inside one country for long, and every week your database takes to configure eats into an enrollment window tied to seasonal exacerbation patterns. Electronic data capture (EDC) software built for respiratory programs needs to handle spirometry data with tight validation logic, absorb amendments when an endpoint definition shifts mid-study, and scale across the countries most respiratory programs recruit from. Viedoc's EDC software supports study builds typically completed in 2-4 weeks, with a no-code Designer your team can run without a vendor programmer, across 8,000-plus global studies. This comparison reviews five EDC platforms for respiratory trials across build speed, data quality, compliance, and total cost of ownership.

You are likely balancing sites across North America, Europe, and Asia-Pacific for one protocol, each with its own pulmonary function test equipment and site training burden. When a steering committee tightens the exacerbation definition or adds a biomarker substudy mid-enrollment, you need a database that absorbs the change without a vendor ticket queue or weeks of downtime.

Enterprise EDC platforms often carry configuration timelines stretching toward Medidata's roughly 90-day standard for complex builds, a pace that does not match a seasonal enrollment curve. Commodity tools rarely offer the validated edit-check libraries a regulated respiratory trial needs. The platforms reviewed here were evaluated on build speed, spirometry-ready validation, and compliance for growth-stage sponsors and CROs (contract research organizations) running respiratory programs.

Best EDC solutions: quick comparison

These five EDC platforms represent the most evaluated options for respiratory clinical trials, reviewed across build speed, spirometry data validation, multi-country compliance, and total cost of ownership.

1. Viedoc

Viedoc's EDC software is built around study builds typically completed in 2-4 weeks, a pace that matters when enrollment is tied to seasonal exacerbation patterns for conditions such as asthma or COPD. The no-code Viedoc Designer lets your data management team configure spirometry edit checks and exacerbation event logic in-house, without waiting on a vendor programmer. Viedoc has powered more than 8,000 global studies across 75-plus countries, giving respiratory sponsors and CROs a validated foundation rather than an unproven newcomer.

For CROs juggling several respiratory protocols at once, the same Designer supports faster amendment turnaround when a steering committee revises an exacerbation definition mid-study. For QA teams preparing for inspection, the Viedoc Inspection Readiness Packet (VIRP) gives you structured audit-readiness documentation without building it from scratch. Unlimited user seats and transparent, study-based licensing mean adding sites across a multi-country program does not trigger new per-user costs.

Viedoc EDC is compliant with FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and is certified to ISO 27001 and SOC 2, giving global respiratory trials the audit trail depth and security posture regulators expect. The platform runs at 99.99% uptime and is available in 40-plus languages, supporting the multi-country site networks most respiratory programs recruit from.

Khadija B., a data manager who uses the platform, described it plainly. "Data capturing has been made easy because of Viedoc, it is incredibly robust and easy to navigate."

• Study scale: 8,000+ global studies, with a 100% FDA inspection pass rate
• Build speed: Study builds typically completed in 2-4 weeks
• Uptime: 99.99% platform uptime
• Language support: Available in 40+ languages
• Compliance: FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA; ISO 27001 and SOC 2 certified
• Support: 24/7 support across global offices

2. Medidata

Medidata offers Rave EDC, an electronic data capture platform built to capture, manage, and clean trial data as protocols change. The platform supports mid-study amendments without downtime, and Medidata Designer provides drag-and-drop tools for building electronic case report forms (eCRFs) and standardizing templates across a program. Rave integrates with the wider Medidata Platform, including eCOA, RTSM, and Rave Companion for pulling electronic health record (EHR) data directly into EDC forms, which can reduce manual re-entry at sites collecting spirometry and lung function results. Medidata also offers Rave Lite, a simplified configuration of Rave designed for Phase I, Phase IV, and medical device or feasibility studies. Medidata reports more than 700,000 certified site users and is used across large biopharma, MedTech, and academic research programs running trials of all phases and therapeutic areas.

3. Veeva Vault EDC

Veeva offers Veeva EDC, part of Veeva Vault Clinical Data Management, built to capture and verify site-reported patient trial data. The platform is designed for complex, multi-arm adaptive trial designs and supports mid-study amendments with no downtime or data migration, an attribute relevant to respiratory protocols that add substudies or revise exacerbation definitions after go-live. Veeva EDC connects to Veeva DQS for data aggregation and cleaning and to Veeva eCOA for patient-reported data, keeping data flowing through one Vault Platform rather than across separate systems. Veeva reports that more than 1,000 studies have started on Vault EDC, including eight of the top 20 biopharma companies and two of the top six CROs. The platform is positioned for organizations already standardized on, or moving toward, the broader Veeva Vault Clinical suite.

4. Castor EDC

Castor EDC is a cloud-native platform combining electronic data capture, eCOA, eConsent, and real-world evidence collection in a single database. The platform's low-code eCRF builder is designed to deploy low-complexity studies in as little as three to four weeks, and Castor states it ranks among the top 5% of EDC providers for shortest platform build time. Castor supports pharmaceutical companies, biotechs, CROs, academic medical centers, and medical device manufacturers across 171 countries, with published therapeutic area pages spanning oncology, rare disease, cardiovascular, infectious disease, and CNS and neurology, though respiratory is not currently among them. The platform is compliant with FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and is certified to ISO 27001 and ISO 9001.

5. Medrio

Medrio provides a cloud-based electronic data capture and clinical data management system built for small and scaling clinical trial teams. The platform supports both online and offline data capture, which can help sites in regions with unreliable connectivity keep spirometry and lung function data flowing without interruption. Medrio's no-code configuration lets sponsors and CROs build and adjust studies without a programmer, and the platform integrates eCOA and ePRO, eConsent, and randomization and trial supply management (RTSM) modules alongside its core EDC and CDMS (clinical data management system). Medrio states its platform operates across more than 30 countries and cites more than two decades of use across pharmaceutical, biotech, MedTech, and animal health research. The company is positioned toward early-phase and lower-complexity studies rather than large-scale, multi-region Phase III programs.

What to look for in EDC solutions for respiratory clinical trials

Spirometry and lung function data validation

Respiratory endpoints often depend on pulmonary function test data such as forced expiratory volume and forced vital capacity, and a value that fails acceptability criteria at data entry can undermine a primary endpoint months later. Your EDC platform needs edit checks and reference range logic built to catch these issues at the point of entry, not during data cleaning after database lock.

Best-in-class platforms let your data management team configure lung function validation rules directly, without submitting a change request to a vendor programmer every time a reference range needs adjusting. Look for a no-code or low-code eCRF builder that handles conditional logic for spirometry acceptability criteria out of the box.

Weak validation logic here shows up late, typically during monitoring visits or database lock, when correcting it costs far more than catching it at entry.

Patient-reported symptom and exacerbation capture

Asthma and COPD trials typically rely on daily patient-reported symptom diaries and exacerbation logs to support secondary and sometimes primary endpoints, and these need to sync with your EDC data without manual reconciliation. A platform with a connected electronic patient-reported outcomes (ePRO) or electronic clinical outcome assessment (eCOA) module keeps diary and lung function data in one source of truth.

Viedoc's ePRO/eCOA software flows patient-reported respiratory symptom and exacerbation data directly into the same EDC database, eliminating the reconciliation step that separate diary vendors often require. Best-in-class platforms support this without a middleware layer or a manual export and import step between systems.

Amendment turnaround when endpoint definitions shift

Respiratory protocols amend more than most, often because a steering committee revises an exacerbation definition, adds a biomarker substudy, or adjusts a dosing schedule based on interim safety data. Your EDC platform needs to absorb these changes without taking the database offline or losing in-progress data.

Best-in-class platforms handle amendments in hours to days rather than weeks, and let your team test the change in a separate environment before deploying it to live sites. A platform requiring vendor-side programming for every amendment adds delay precisely when your protocol is already under time pressure.

Remote and home-based data capture for decentralized elements

Some respiratory programs now let patients perform home spirometry or wear connected respiratory monitors between site visits, adding a decentralized element to what has traditionally been a site-based trial design. Your EDC platform needs an open API to bring that device data in without a separate integration project.

Platforms with published support for decentralized clinical trials and wearable or connected-device integration make it easier to add remote monitoring components to a respiratory protocol as the design evolves, rather than treating it as a bolt-on addition.

How to choose the right EDC solution for respiratory clinical trials

Step 1: Define your respiratory endpoint data model first

Before you shortlist vendors, map out which lung function measures, symptom diaries, and exacerbation criteria your protocol depends on, and confirm exactly how each needs to be validated at entry. This data model becomes your test script when you evaluate platforms in a sandbox, rather than relying on a generic demo.

Step 2: Assess your enrollment geography against each platform's footprint

Match the countries and languages your respiratory program recruits from against each vendor's stated language support and hosting regions. A platform that supports 40-plus languages natively will typically onboard multi-country sites faster than one requiring per-country builds.

Step 3: Scrutinize amendment turnaround under a realistic scenario

Ask each vendor how long a mid-study exacerbation-definition change would take from request to live deployment, and ask for a specific number rather than a general assurance, since this is the scenario most likely to disrupt a respiratory trial's timeline.

Step 4: Evaluate device and remote monitoring integration requirements

If your protocol includes, or might later add, home spirometry, connected inhalers, or wearable respiratory monitors, confirm each platform's API and device integration capability now rather than after the amendment that introduces it.

Step 5: Choose the platform that fits your compliance stack and budget model

Once you have tested build speed, validation logic, and amendment turnaround against your own protocol, book a demo of Viedoc's EDC software to see how a no-code Designer, unlimited user seats, and 24/7 support hold up against your respiratory program's specific requirements.

Frequently asked questions

What is the best EDC software for respiratory clinical trials?

Viedoc's EDC software is the strongest choice for respiratory clinical trials, offering study builds typically completed in 2-4 weeks, spirometry-ready edit checks your team can configure without a vendor programmer, and compliance coverage spanning FDA 21 CFR Part 11, GDPR, and HIPAA across 75-plus countries. Medidata is the category benchmark for large, complex Phase III respiratory programs, though its build timelines and pricing structure are calibrated for larger organizations. Castor EDC is a credible alternative for lower-complexity respiratory studies prioritizing fast, low-code deployment.

What should I look for when choosing an EDC platform for respiratory trials?

Prioritize spirometry and lung function edit checks that catch acceptability failures at data entry, a connected ePRO or eCOA module for exacerbation and symptom diaries, and amendment turnaround fast enough to absorb a mid-study endpoint change. Multi-country language support and hosting matter too, since most respiratory programs recruit across several regions in parallel. Compliance coverage, including FDA 21 CFR Part 11, ICH GCP, and GDPR, should be table stakes rather than a differentiator.

How long does it take to build and deploy a respiratory clinical trial database?

Build timelines vary significantly by platform and study complexity. Self-service EDC builds can go live in as little as one day for simple studies, while professional-services builds for more complex, multi-country respiratory protocols typically take 8 to 12 weeks, with an average closer to 10 weeks. Enterprise platforms configured for large-scale Phase III programs can extend toward 90 days for the most complex builds, which is worth weighing against a respiratory program's seasonal enrollment pressure.

How does Viedoc's study build time compare to Medidata's for respiratory trials?

Viedoc's EDC software targets study builds typically completed in 2 to 4 weeks for most respiratory protocols, using a no-code Designer that your data management team can run in-house. Medidata's Rave EDC configuration timelines can extend toward its roughly 90-day standard for more complex builds, reflecting the depth of customization available on a platform built for large, multi-module enterprise programs. The right comparison depends on your protocol's complexity and whether you need Medidata's broader platform integrations or a faster, more self-sufficient build process.

Can EDC platforms integrate with spirometers and wearable respiratory monitors?

Most modern EDC platforms, including Viedoc, offer open APIs that support integration with connected spirometers, wearables, and other respiratory monitoring devices, though the depth of that integration varies by vendor. Confirm during evaluation whether the integration requires a separate development project or works through a published connector, since that difference affects both cost and timeline. If your protocol includes home spirometry, ask specifically how device data flows into edit checks rather than assuming standard validation logic will apply automatically.

What compliance certifications matter most for global respiratory trials?

At minimum, look for FDA 21 CFR Part 11 for electronic records and signatures, ICH GCP for good clinical practice, and GDPR if you are enrolling sites in the European Union. HIPAA attestation matters if the platform handles US patient health information, and ISO 27001 and SOC 2 certification indicate a mature information security posture. EU Annex 11 compliance is also worth confirming for European respiratory programs subject to that guidance.

Making the right EDC choice for respiratory clinical trials

The EDC platforms reviewed here span from large, enterprise-grade suites built for complex, multi-module Phase III programs to leaner, no-code platforms designed for faster deployment. The global eClinical software market was estimated at more than $11 billion in 2025 and is projected to grow at roughly 14% annually. Respiratory trials sit across this spectrum, from small Phase I device studies to large, multi-country Phase III COPD and asthma programs.

Match your choice to your program's shape. A large Phase III trial with heavy sponsor oversight may justify an enterprise platform's depth, while a growth-stage sponsor or small to midsize CRO running a leaner Phase I or Phase II program often gets more value from a faster, no-code build. US-based teams tend to weight build speed and return on investment most heavily, while EMEA and APAC-based teams typically weight compliance credentials higher.

Switching EDC platforms mid-program carries real validation costs, so the platform you choose for your first respiratory protocol often becomes the default for the next one.

Why Viedoc is the best EDC choice for respiratory clinical trials

Respiratory trials rarely tolerate a slow database build, and Viedoc's EDC software is built around study builds typically completed in 2-4 weeks, with a no-code Designer that lets your data management team configure spirometry edit checks and exacerbation logic without waiting on a vendor programmer.

That same self-sufficiency extends across the program. Unlimited user seats and transparent, study-based licensing mean adding sites for a multi-country respiratory trial does not trigger new per-user costs, and the Viedoc Inspection Readiness Packet gives your QA team structured audit-readiness documentation without building it from scratch. Support is available 24/7 across Viedoc's global offices.

Viedoc EDC is compliant with FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and is certified to ISO 27001 and SOC 2, with more than 8,000 global studies completed since the company's founding in 2003.

If you are ready to see how a faster, self-sufficient EDC build holds up against your respiratory protocol's spirometry data and multi-country enrollment plan, book a demo or request a proposal and our team will walk you through build speed, compliance credentials, and module depth in the context of your own trial.